Retatrutide 10mg Research Lyophilized Peptide

Cellevia Labs supplies retatrutide (10mg, lyophilized) for in-vitro and preclinical laboratory research. Retatrutide is a synthetic peptide investigated in the scientific literature as a triple agonist of the GIP, GLP-1, and glucagon receptors. This listing is intended for qualified researchers, laboratories, and institutions conducting studies under appropriate protocols.

This product is not a drug, dietary supplement, or cosmetic. It is not approved by the FDA or any regulatory body for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease. It is sold strictly for in-vitro laboratory and analytical research use by qualified professionals.

Product Specifications

• Compound: Retatrutide (RETA)
• Molecular formula: C223H341N45O68
• Molecular weight: ~4,731 g/mol
• Purity: ≥98%, confirmed by HPLC
• Format: Sterile lyophilized powder, single-use vial
• Net content: 10mg per vial
• Storage (reconstituted): -20°C, desiccated, protected from light
• Certificate of Analysis: Provided with every batch

Quality & Documentation

Every batch ships with a third-party Certificate of Analysis (CoA) confirming identity and purity via HPLC and mass spectrometry, so researchers can verify material integrity before use in their protocols. Cellevia Labs maintains batch-level traceability and cold-chain shipping to preserve peptide stability from dispatch to delivery.

Intended Use

For laboratory, analytical, and preclinical research applications only — including receptor-binding studies, in-vitro assay work, and formulation research. Not for human consumption, ingestion, injection, or veterinary application under any circumstances.